Higher insulin resistance and systemic inflammation, indicated by a higher triglyceride to HDL cholesterol ratio and higher hsCRP level, may also contribute to the development of metabolic syndrome in subjects with low serum adiponectin levels and high VFA. This evidence concerns the gene ADIPOQ and metabolic syndrome.